Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 282

1.

Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.

Gillio-Tos A, Bicalho Mda G, Fiano V, Grasso C, Tarallo V, De Marco L, Trevisan M, Xavier M, Slowik R, Carvalho NS, Maestri CA, Lacerda HM, Zugna D, Richiardi L, Merletti F.

BMC Cancer. 2012 Dec 24;12:618. doi: 10.1186/1471-2407-12-618.

2.

CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.

Chatterjee K, Dandara C, Hoffman M, Williamson AL.

BMC Cancer. 2010 Jun 10;10:278. doi: 10.1186/1471-2407-10-278.

3.

Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study.

McCormick TM, Canedo NH, Furtado YL, Silveira FA, de Lima RJ, Rosman AD, Almeida Filho GL, Carvalho Mda G.

Diagn Pathol. 2015 Jun 2;10:59. doi: 10.1186/s13000-015-0283-3.

4.

Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.

Pista A, de Oliveira CF, Lopes C, Cunha MJ; CLEOPATRE Portugal Study Groupa.

Int J Gynecol Cancer. 2013 Mar;23(3):500-6. doi: 10.1097/IGC.0b013e318280f26e.

PMID:
23392401
5.

Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese.

Chan PK, Cheung TH, Lin CK, Siu SS, Yim SF, Lo KW, Cheung JL, Tam AO, Tang JW.

J Med Virol. 2007 Jul;79(7):970-6.

PMID:
17516530
6.

Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.

Hublarova P, Hrstka R, Rotterova P, Rotter L, Coupkova M, Badal V, Nenutil R, Vojtesek B.

Int J Gynecol Cancer. 2009 Apr;19(3):321-5. doi: 10.1111/IGC.0b013e31819d8a5c.

PMID:
19407553
7.
8.

Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis.

Flatley JE, McNeir K, Balasubramani L, Tidy J, Stuart EL, Young TA, Powers HJ.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2782-9. doi: 10.1158/1055-9965.EPI-09-0493. Epub 2009 Sep 15.

9.

Analysis of human papillomavirus and Epstein-Barr virus infection and aberrant death-associated protein kinase methylation in high-grade squamous intraepithelial lesions.

Lattario F, Furtado YL, Fonseca R, Silveira FA, do Val IC, Almeida G, Carvalho MG.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):785-9. Epub 2007 Sep 14.

PMID:
17868341
10.

Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix.

Ferguson R, Ramanakumar AV, Koushik A, Coutlée F, Franco E, Roger M; Biomarkers of Cervical Cancer Risk Study Team.

Int J Cancer. 2012 Aug 1;131(3):E312-9. doi: 10.1002/ijc.27356. Epub 2012 Jan 3.

11.

Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.

Wang SS, Zuna RE, Wentzensen N, Dunn ST, Sherman ME, Gold MA, Schiffman M, Wacholder S, Allen RA, Block I, Downing K, Jeronimo J, Carreon JD, Safaeian M, Brown D, Walker JL.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):113-20. doi: 10.1158/1055-9965.EPI-08-0591.

12.

Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women.

Suthipintawong C, Siriaunkgul S, Tungsinmunkong K, Pientong C, Ekalaksananan T, Karalak A, Kleebkaow P, Vinyuvat S, Triratanachat S, Khunamornpong S, Chongsuwanich T.

Asian Pac J Cancer Prev. 2011;12(4):853-6.

13.

Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.

Huang TH, Lai HC, Liu HW, Lin CJ, Wang KH, Ding DC, Chu TY.

Int J Gynecol Cancer. 2010 May;20(4):513-9. doi: 10.1111/IGC.0b013e3181c7fe6e.

PMID:
20442585
14.

Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.

Sánchez-Lander J, Cortiñas P, Loureiro CL, Pujol FH, Medina F, Capote-Negrín L, Bianchi G, García-Barriola V, Ruiz-Benni A, Avilán-Rovira J, Acosta H.

Cancer Epidemiol. 2012 Oct;36(5):e284-7. doi: 10.1016/j.canep.2012.04.005. Epub 2012 May 17.

PMID:
22608058
15.

High prevalence of human papillomavirus DNA detected in cervical swabs from women in southern Selangor, Malaysia.

Chong PP, Asyikin N, Rusinahayati M, Halimatun S, Rozita R, Ng CK, Hamilton WH, Tan BC, Noraihan N, Rohani A, Faezah H, Latiffah L, Maha A, Sabariah AR.

Asian Pac J Cancer Prev. 2010;11(6):1645-51.

16.

Risk factors for cervical neoplasia in Denmark.

Kjaer SK.

APMIS Suppl. 1998;80:1-41.

PMID:
9693662
17.

HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus.

Simões RT, Gonçalves MA, Castelli EC, Júnior CM, Bettini JS, Discorde ML, Duarte G, Quintana SM, Simões AL, Moreau P, Carosella ED, Soares EG, Donadi EA.

Mod Pathol. 2009 Aug;22(8):1075-82. doi: 10.1038/modpathol.2009.67. Epub 2009 May 1.

18.

Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.

Hesselink AT, Heideman DA, Steenbergen RD, Coupé VM, Overmeer RM, Rijkaart D, Berkhof J, Meijer CJ, Snijders PJ.

Clin Cancer Res. 2011 Apr 15;17(8):2459-65. doi: 10.1158/1078-0432.CCR-10-2548. Epub 2011 Mar 9.

19.
20.

Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort.

Safaeian M, Quint K, Schiffman M, Rodriguez AC, Wacholder S, Herrero R, Hildesheim A, Viscidi RP, Quint W, Burk RD.

J Natl Cancer Inst. 2010 Dec 1;102(23):1794-804. doi: 10.1093/jnci/djq436. Epub 2010 Nov 23.

Items per page

Supplemental Content

Write to the Help Desk